Web of Science: 7 citas, Scopus: 8 citas, Google Scholar: citas,
Distinct dopamine D2 receptor antagonists differentially impact D2 receptor oligomerization
Wouters, Elise (Laboratory of Toxicology. Department of Bioanalysis. Faculty of Pharmaceutical Sciences. Ghent University)
Ricarte Marín, Adrián (Universitat Autònoma de Barcelona. Institut de Neurociències)
Dalton, James Andrew Rupert (Universitat Autònoma de Barcelona. Institut de Neurociències)
Giraldo, Jesús (Universitat Autònoma de Barcelona. Institut de Neurociències)
Stove, Christophe. (Laboratory of Toxicology. Department of Bioanalysis. Faculty of Pharmaceutical Sciences. Ghent University)

Fecha: 2019
Resumen: Dopamine D receptors (DR) are known to form transient homodimer complexes, of which the increased formation has already been associated with development of schizophrenia. Pharmacological targeting and modulation of the equilibrium of these receptor homodimers might lead to a better understanding of the critical role played by these complexes in physiological and pathological conditions. Whereas agonist addition has shown to prolong the DR dimer lifetime and increase the level of dimer formation, the possible influence of DR antagonists on dimerization has remained rather unexplored. Here, using a live-cell reporter assay based on the functional complementation of a split Nanoluciferase, a panel of six DR antagonists were screened for their ability to modulate the level of DR dimer formation. Incubation with the DR antagonist spiperone decreased the level of DR dimer formation significantly by 40-60% in real-time and after long-term (≥16 h) incubations. The fact that dimer formation of the well-studied A-DR dimer was not altered following incubation with spiperone supports the specificity of this observation. Other DR antagonists, such as clozapine, risperidone, and droperidol did not significantly evoke this dissociation event. Furthermore, molecular modeling reveals that spiperone presents specific Tyr199 and Phe390 conformations, compared to clozapine, which may determine DR homodimerization.
Nota: Número d'acord de subvenció IWT/SBO/140028
Nota: Número d'acord de subvenció MICIINU/SAF2017-87199-R
Derechos: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. Creative Commons
Lengua: Anglès
Documento: article ; recerca ; publishedVersion
Materia: G protein-coupled receptor (GPCR) ; Dimerization ; Oligomerization ; Protein complementation assay ; NanoLuc binary technoogy (NanoBiT) ; Dopamine D2 receptor
Publicado en: International journal of molecular sciences, Vol. 20 Núm. 7 (january 2019) , p. 1686, ISSN 1422-0067

DOI: 10.3390/ijms20071686
PMID: 30987329


25 p, 3.0 MB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut de Neurociències (INc)
Artículos > Artículos de investigación
Artículos > Artículos publicados

 Registro creado el 2020-01-10, última modificación el 2020-08-02



   Favorit i Compartir